Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RUCAPARIB CAMSYLATE vs RUPATADINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RUCAPARIB CAMSYLATE vs RUPATADINE: Safety Overview

Metric RUCAPARIB CAMSYLATE RUPATADINE
Total FAERS Reports 8,240 767
Deaths Reported 448 73
Death Rate 5.4% 9.5%
Hospitalizations 1,148 436
Average Patient Age 65.1 yrs 55.0 yrs
% Female Patients 95.2% 76.3%
FDA Approval Date Dec 19, 2016 N/A
Manufacturer pharmaand GmbH N/A
Route ORAL N/A
Marketing Status Prescription N/A